Anticoagulant and antiplatelet therapy for coronary heart disease and peripheral artery disease patients

Coronary heart disease (CHD) and peripheral artery disease (PAD) have recently become major diseases threatening human health. The drug therapy for CHD and PAD is mainly to prevent the formation of new atherosclerosis and stabilize the existing lesions and the most commonly used drug therapy is antiplatelet and anticoagulant therapy. This paper compares a large number of clinical trials for patients with coronary heart disease and peripheral artery disease.